Testing effectiveness (Phase 2)UnknownNCT04502680
What this trial is testing
Maintenance Treatment With Eribulin Mesylate Versus Observation in Triple Negative Breast Cancer Patients
Who this might be right for
Triple Negative Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 100